– Pelin Yunusoğlu, General Manager of Sanofi Turkey, Iran and Levantine Treatments:

OncoSprint is targeted at cancer and aging because around 37 percent of new cancer cases are people over the age of 70, and that person is predicted to increase by another two by 2040.

ISTANBUL – Solutions to the first requirements and problems before cancer and old age, in cooperation with Sanofi Turkey’s ReDis Innovation “Program to end with the first approved season Demo Day”, which plans to end with coSprint.

In the evaluations to be made within the scope of the program, the highest level of pre-school evaluations was determined. The aforementioned issue was announced on the Day of Regulation in IT Valley.

OncoSprint was implemented as an innovation program that aims to provide a fast and effective view to complex problems of cancer and old age patients, in cooperation with opinion leaders, academicians, public institution days, associations and entrepreneurs.

The program is a rapid technological development “Sprint Preparation” program developed by Google. In this way, while solutions for cancer and aging are produced, the stages from reshaping to testing at targets are completed in approximately one facility.

10 entrepreneurs should have attended this 1-month training, which includes training on the right to participate in the program and mentoring, at OncoSprint as dressing the first people-related categories, digital health technologies, and technical technologies, distance education health services, educational technologies, technologies and health supplements.

Of the 6 who found maturation throughout this period, Initiocell and Senyorapp in the field of deep technology, and in the category oncology, hematology, geriatrics, the public and their evaluations of pictures of their patients were selected as the most impressive ones.

One representative, influenced by the jury, also won sponsorships to benefit from Medica Düsseldorf.

1 in 5 deaths in school is due to cancer

Sanofi Manager Turkey, given to the people whose opinions were given in the statement, the developers who completed the innovation systems in Turkey and their expectations for the completion of OncoSprint-trained treatments, for which they developed the successful PharmUp entrepreneurship platforms for 3 years, for the General targets of Turkey, and Levant-Specific Therapies.

Yunusoglu said:

“Onco is getting sick about cancer and old age with pressure, because it is estimated about 37 of the old cancer diagnoses, about 37 of those over 70 years old. And it is among the people from the world. Age from the age section and is in Turkey. These people are 2023 Maybe it’s not visible from .

It will talk about people of future age at the early times of the intersection of the future and the age. It also has the right quality of life to grow old with, or the best possible life after cancer. As Sanofi, we strongly believe that Turkey can be an example for the patient. You would consider shopping together in order to fill out the deficiencies on this site and find it systematically. To heartily support all the finalists, especially the first-term winner of OncoSprint, which we have brought to life with this belief.”

ReDis Innovation Founder and Selin Arslan reported a planning of the last 15 entrepreneurial economic development in Turkey.

Arslanhan continued:

“One of the most important in the current situation is a thematic program for applications for everyone in the country. A thematic program on cancer and old age. Encouraging promoters in the technologies of such programs.”

Solution understanding shouldn’t just face a research-destroying attack

Informatics General Manager Ahmet Serdar İbrahimcioğlu said, “We set out as Informatics Valley, to plan to develop comprehensive education in order to plan the targeted growth to grow.” their uses.

“What they can benefit from is İbrahimcioğlu, who can benefit from his work. It is to avoid talking about seeing it holistic.” made its assessment.

İbrahimcioğlu delivered the first part of his product without completing it, and said, “This is on its way, it should be just to be examined about how it will be. (AA)